• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体表面修饰在口服药物传递中的最新进展。

Recent advances in liposome surface modification for oral drug delivery.

机构信息

Department of Biomedical Engineering, College of Life Science & Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

National Engineering Research Center for Nano-Medicine, Huazhong University of Science & Technology, Wuhan 430074, China.

出版信息

Nanomedicine (Lond). 2016 May;11(9):1169-85. doi: 10.2217/nnm.16.9. Epub 2016 Apr 13.

DOI:10.2217/nnm.16.9
PMID:27074098
Abstract

Oral delivery via the gastrointestinal (GI) tract is the dominant route for drug administration. Orally delivered liposomal carriers can enhance drug solubility and protect the encapsulated theraputic agents from the extreme conditions found in the GI tract. Liposomes, with their fluid lipid bilayer membrane and their nanoscale size, can significantly improve oral absorption. Unfortunately, the clinical applications of conventional liposomes have been hindered due to their poor stability and availability under the harsh conditions typically presented in the GI tract. To overcome this problem, the surface modification of liposomes has been investigated. Although liposome surface modification has been extensively studied for oral drug delivery, no review exists so far that adequately covers this topic. The purpose of this paper is to summarize and critically analyze emerging trends in liposome surface modification for oral drug delivery.

摘要

口服经胃肠道(GI)给药是药物给药的主要途径。口服递药的脂质体载体可以提高药物的溶解度,并保护包裹的治疗剂免受胃肠道中发现的极端条件的影响。脂质体具有流体脂质双层膜和纳米级尺寸,可以显著改善口服吸收。不幸的是,由于其在胃肠道中通常存在的恶劣条件下的稳定性和可用性差,传统脂质体的临床应用受到了阻碍。为了解决这个问题,已经研究了脂质体的表面修饰。尽管已经对脂质体表面修饰进行了广泛的研究用于口服药物递送,但目前还没有一篇综述能够充分涵盖这个主题。本文的目的是总结和批判性分析用于口服药物递送的脂质体表面修饰的新兴趋势。

相似文献

1
Recent advances in liposome surface modification for oral drug delivery.脂质体表面修饰在口服药物传递中的最新进展。
Nanomedicine (Lond). 2016 May;11(9):1169-85. doi: 10.2217/nnm.16.9. Epub 2016 Apr 13.
2
Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging.口服给药后实时体内成像评估脂质体在胃肠道中的行为。
Drug Dev Ind Pharm. 2018 Apr;44(4):608-614. doi: 10.1080/03639045.2017.1405972. Epub 2017 Nov 30.
3
Potential of Liposomes for Enhancement of Oral Drug Absorption.脂质体增强口服药物吸收的潜力。
Curr Drug Deliv. 2017;14(2):289-303. doi: 10.2174/1567201813666160115125756.
4
Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems.脂质体与天然胆汁盐提取物孵育时的特性和行为:对其作为口服给药系统应用的启示。
Soft Matter. 2014 Sep 21;10(35):6677-85. doi: 10.1039/c4sm00981a.
5
Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology.采用新型天然纤维交织脂质体技术制备、表征并研究脂质体小檗碱的体外和体内研究。
Eur J Pharm Biopharm. 2024 Oct;203:114431. doi: 10.1016/j.ejpb.2024.114431. Epub 2024 Jul 31.
6
[Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].[脂质体作为药物载体系统。脂质体的制备、分类及治疗优势]
Acta Pharm Hung. 2001;71(1):114-8.
7
Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery.层状功能化脂质体的口服药物传递的分子设计。
ACS Appl Mater Interfaces. 2020 Sep 30;12(39):43341-43351. doi: 10.1021/acsami.0c13504. Epub 2020 Sep 21.
8
Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.含胆汁盐的囊泡:用于口服递送难溶性药物以及基于肽/蛋白质的治疗剂或疫苗的有前景的药物载体。
Drug Deliv. 2016 Jul;23(6):1847-67. doi: 10.3109/10717544.2014.976892. Epub 2014 Nov 12.
9
Effect of liposomes on the absorption of water-soluble active pharmaceutical ingredients via oral administration.脂质体对口服水溶性活性药物成分吸收的影响。
Curr Pharm Des. 2013;19(37):6647-54. doi: 10.2174/1381612811319370008.
10
Oral delivery of vancomycin by tetraether lipid liposomes.通过四醚脂质体口服递送万古霉素。
Eur J Pharm Sci. 2017 Oct 15;108:111-118. doi: 10.1016/j.ejps.2017.07.013. Epub 2017 Jul 14.

引用本文的文献

1
Therapeutic peptides and their delivery using lipid-based nanoparticles.治疗性肽及其基于脂质的纳米颗粒递送
Tzu Chi Med J. 2025 May 2;37(3):223-234. doi: 10.4103/tcmj.tcmj_321_24. eCollection 2025 Jul-Sep.
2
Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms.肺癌疫苗策略:探索从传统平台到基于RNA平台的范围
Front Bioeng Biotechnol. 2025 Jun 23;13:1617352. doi: 10.3389/fbioe.2025.1617352. eCollection 2025.
3
Immunoprevention of non-viral cancers: challenges and strategies for early intervention.
非病毒性癌症的免疫预防:早期干预的挑战与策略
Cancer Cell Int. 2025 May 28;25(1):196. doi: 10.1186/s12935-025-03817-8.
4
Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects.用于提高溃疡性结肠炎药物递送系统效率的口服脂质纳米粒:最新进展与未来前景
Pharmaceutics. 2025 Apr 23;17(5):547. doi: 10.3390/pharmaceutics17050547.
5
Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome.抗抑郁药物的进展:药物发现与基于聚合物的药物递送系统以改善治疗效果。
Biomedicines. 2025 Apr 29;13(5):1081. doi: 10.3390/biomedicines13051081.
6
Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery.基于纳米技术的疫苗开发策略:加速创新与交付
Biomater Transl. 2025 Mar 25;6(1):55-72. doi: 10.12336/biomatertransl.2025.01.005. eCollection 2025.
7
Microfluidic fabrication of pectin-coated liposomes for drug delivery.用于药物递送的果胶包被脂质体的微流体制备
Drug Deliv Transl Res. 2025 Feb 22. doi: 10.1007/s13346-025-01812-0.
8
Recent development of micro-nano carriers for oral antineoplastic drug delivery.用于口服抗肿瘤药物递送的微纳米载体的最新进展。
Mater Today Bio. 2025 Jan 3;30:101445. doi: 10.1016/j.mtbio.2025.101445. eCollection 2025 Feb.
9
Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers.用于克服黏液和上皮屏障的有效递肽药物的自适应性药物输送系统的设计。
AAPS J. 2024 Sep 12;26(5):102. doi: 10.1208/s12248-024-00971-1.
10
Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility/Bioavailability and Administration Routes.用于先进药物递送的载体系统:改善药物溶解度/生物利用度及给药途径
Pharmaceutics. 2024 Jun 25;16(7):852. doi: 10.3390/pharmaceutics16070852.